[CLDX] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
26-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 8.46%
YoY- -11.11%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 1,613 333 3,786 887 1,764 3,456 1,874 -2.46%
PBT -26,487 -20,148 -22,839 -10,447 -9,402 -22,923 -32,307 -3.25%
Tax -2,796 -874 -939 -4,448 -8,746 -19,082 -5,090 -9.49%
NP -23,691 -20,148 -21,900 -10,447 -9,402 -3,841 -32,307 -5.03%
Tax Rate - - - - - - - -
Total Cost 25,304 20,481 25,686 11,334 11,166 7,297 34,181 -4.88%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -1,468.75 -6,050.45 -578.45 -1,177.79 -532.99 -111.14 -1,723.96 -2.63%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.50 -0.43 -0.55 -0.64 -0.81 -0.42 -4.49 -30.62%
EPS Diluted -0.50 -0.43 -0.55 -0.64 -0.81 -0.41 -4.49 -30.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.